Latest Insider Transactions at Atossa Therapeutics, Inc. (ATOS)
This section provides a real-time view of insider transactions for Atossa Therapeutics, Inc. (ATOS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ATOSSA THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ATOSSA THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 10
2024
|
Jonathan Finn |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$25,000
$1.77 P/Share
|
|
Nov 15
2023
|
Gregory L Weaver Former EVP, CFO, & Director |
SELL
Open market or private sale
|
Direct |
50,000
-99.89%
|
$0
$0.65 P/Share
|
|
Jun 20
2023
|
Gregory L Weaver Former EVP, CFO, & Director |
BUY
Open market or private purchase
|
Direct |
50,000
+49.97%
|
$0
$0.97 P/Share
|
|
Jul 02
2021
|
Gregory L Weaver Former EVP, CFO, & Director |
SELL
Open market or private sale
|
Direct |
107,497
-100.0%
|
$537,485
$5.58 P/Share
|
|
Jul 02
2021
|
Gregory L Weaver Former EVP, CFO, & Director |
SELL
Payment of exercise price or tax liability
|
Direct |
57,084
-34.68%
|
$342,504
$6.4 P/Share
|
|
Jul 02
2021
|
Gregory L Weaver Former EVP, CFO, & Director |
BUY
Exercise of conversion of derivative security
|
Direct |
164,581
+39.91%
|
$493,743
$3.06 P/Share
|